Androgen receptor CAG repeat polymorphism in prostate cancer (2001)
- Authors:
- Autor USP: NAGAI, MARIA APARECIDA - FM
- Unidade: FM
- Subjects: NEOPLASIAS; PRÓSTATA
- Language: Inglês
- Imprenta:
- Conference titles: Reunião Anual da Sociedade Brasileira de Bioquímica e Biologia Molecular
-
ABNT
SANTOS, M. L. e SARKIS, Álvaro e NAGAI, Maria Aparecida. Androgen receptor CAG repeat polymorphism in prostate cancer. 2001, Anais.. Caxambu: Faculdade de Medicina, Universidade de São Paulo, 2001. . Acesso em: 23 abr. 2024. -
APA
Santos, M. L., Sarkis, Á., & Nagai, M. A. (2001). Androgen receptor CAG repeat polymorphism in prostate cancer. In . Caxambu: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Santos ML, Sarkis Á, Nagai MA. Androgen receptor CAG repeat polymorphism in prostate cancer. 2001 ;[citado 2024 abr. 23 ] -
Vancouver
Santos ML, Sarkis Á, Nagai MA. Androgen receptor CAG repeat polymorphism in prostate cancer. 2001 ;[citado 2024 abr. 23 ] - High prevalence of P16 genetic alterations in head and neck tumors
- Alterations of p16 gene in head and neck tumors
- Distinct chrosomal deleted regions defining different subsets head and neck tumors
- Estudo de marcadores de microssatelites para o cromossomo 2 em amostras de tumores de cabeca e pescoco
- Oncogenese
- Analysis of differentially expressed genes between prostate cancer cell lines regarding androgen receptor status
- In silico analyses identify lncRNAs: WDFY3-AS2, BDNF-AS and AFAP1-AS1 as potential prognostic factors for patients with triple-negative breast tumors
- The transcripts of SFRP1, CEP63 and EIF4G2 genes are frequently downregulated in transitional cel carcinomas of the bladder
- Efeito do IGF-I e do 17B-estradiol sobre a expressão dos genes PHLDA1 e PAWR
- Identification of Differentially Expressed Genes Associated with ERBB2 Over-expression in Human Mammary Cells in Response to Docetaxel
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
